Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Hinge Health Inc shares valued at $23,202,112 were sold by Bessemer Venture Partners X L. on May 23 ’25. At $32.00 per share, Bessemer Venture Partners X L. sold 725,066 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Atomico Advisors IV, Ltd. sold 2,651,103 shares, netting a total of over 84,835,296 in proceeds. Following the sale of shares at $32.00 each, the insider now holds 0 shares.
Before that, Insight Holdings Group, LLC had sold 1,250,000 shares from its account. In a trade valued at $40,000,000, the 10% Owner traded Hinge Health Inc shares for $32.00 each. Upon closing the transaction, the insider’s holdings decreased to 1,250,000 shares, worth approximately $0.0.
As published in their initiating research note from William Blair on June 16, 2025, Hinge Health Inc [HNGE] has been an Outperform. Analysts at Truist started covering the stock with ‘”a Buy”‘ outlook in a report released in mid June. As of June 16, 2025, Stifel has initiated its “Buy” rating for HNGE. Earlier on June 16, 2025, RBC Capital Mkts initiated its rating. Their recommendation was “an Outperform” for HNGE stock.
Analyzing HNGE Stock Performance
On last trading session,, Hinge Health Inc [NYSE: HNGE] plunged -1.52% to $44.14. The stock’s lowest price that day was $43.7629, but it reached a high of $45.0 in the same session. During the last five days, there has been a drop of approximately -1.05%.
Support And Resistance Levels for Hinge Health Inc (HNGE)
According to the 24-hour chart, there is a support level at 43.60, which, if violated, would cause prices to drop to 43.06. In the upper region, resistance lies at 44.84. The next price resistance is at 45.54. RSI (Relative Strength Index) is 53.80 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Hinge Health Inc (HNGE)?
In terms of Hinge Health Inc share price expectations, FactSet research, analysts set an average price target of 45 in the next 12 months, up nearly 0.4% from the previous closing price of $44.82. Analysts anticipate Hinge Health Inc stock to reach 48 by 2025, with the lowest price target being 41. On June 16, 2025, Raymond James assigned a price target of “an Outperform” to the stock and initiated coverage with a $45.
